3 min read Health Arlo-cel Shows Promise in Treating Relapsed Myeloma Patients Editorial 22 October, 2025 The novel GPRC5D-targeted CAR T-cell therapy, known as arlocabtagene autoleucel (arlo-cel), has demonstrated significant...Read More
